Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways

American Journal of Physiology - Renal Physiology

Volumn 273, Issue 2 42-2, 1997, Pages

  Imig, John D ^a   Deichmann, Paul C ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Cyclooxygenase 2; Cytochrome P 450; Endothelium derived hyperpolarizing factor; Epoxygenase; Norepinephrine; Phospholipase A2; Renal hemodynamics

Indexed keywords

ANGIOTENSIN; CYTOCHROME P450; LIPOXYGENASE; NORADRENALIN; PHOSPHOLIPASE A2; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ARTERIOLE; ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME INHIBITION; HORMONE ACTION; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

EID: 0030865284     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Antonipillai, I., R. Horton, R. Natarajan, and J. Nadler. A 12-lipoxygenase product of arachidonate metabolism is involved in angiotensin action on renin release. Endocrinology 125: 2028-2034, 1989.
2. Antonipillai, I., J. L. Nadler, E. C. Robin, and R. Horton. The inhibitory role of 12- and 15-lipoxygenase products on renin release. Hypertension 10: 61-66, 1987.
3. Arima, S., Y. L. Ren, L. A. Juncos, O. A. Carretero, and S. Ito. Glomerular prostaglandins modulate vascular reactivity of the downstream efferent arterioles. Kidney Int. 45: 650-658, 1994.
4. Becker, B. N., H. F. Cheng, K. D. Burns, and R. C. Harris. Polarized rabbit type 1 angiotensin II receptors manifest differential rates of endocytosis and recycling. Am. J. Physiol. 269 (Cell Physiol. 38): C1048-C1056, 1995.
5. Bell-Quilley, C. P., Y. S. R. Lin, S. D. Hilchey, E. D. Drugge, and J. C. McGiff. Renovascular actions of angiotensin II in the isolated kidney of the rat: Relationship to lipoxygenases. J. Pharmacol. Exp. Ther. 267: 676-682, 1993.
6. Bugge, J. F., and E. S. Stokke. Angiotensin II and renal prostaglandin release in the dog. Interactions in controlling renal blood flow and glomerular filtration rate. Acta Physiol. Scand. 150: 431-440, 1994.
7. Campbell, W. B., D. Gebremedhin, P. F. Pratt, and D. R. Harder. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78: 415-423, 1996.
8. Capdevila, J. H., S. Wei, J. Yan, A. Karara, H. R. Jacobson, J. R. Falck, F. P. Guengerich, and R. N. DuBois. Cytochrome P-450 arachidonic acid epoxygenase: regulatory control of the renal epoxygenase by dietary salt loading. J. Biol. Chem. 267: 21720-21726, 1992.
9. Chatziantoniou, C., and W. J. Arendshorst. Prostaglandin interactions with angiotensin, norepinephrine, and thromboxane in rat renal vasculature. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F68-F76, 1992.
10. Chatziantoniou, C., and W. J. Arendshorst. Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats. Am. J. Physiol. 263 (Renal Fluid Electrolyte Physiol. 32): F573-F580, 1992.
11. Edwards, R. M. Effects of prostaglandins on vasoconstrictor action in isolated renal arterioles. Am. J. Physiol. 248 (Renal Fluid Electrolyte Physiol. 17): F779-F784, 1985.
12. Griswold, D. E., and J. L. Adams. Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Med. Res. Rev. 16: 181-206, 1996.
13. Harder, D. R., W. B. Campbell, and R. J. Roman. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J. Vasc. Res. 32: 79-92, 1995.
14. Harris, R. C., J. A. McKanna, Y. Akai, H. R. Jacobson, R. N. DuBois, and M. D. Breyer. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J. Clin. Invest. 94: 2504-2510, 1994.
15. Harrison-Bernard, L. M., and P. K. Carmines. Impact of cyclo-oxygenase blockade on juxtamedullary microvascular responses to angiotensin II in rat kidney. Clin. Exp. Pharmacol. Physiol. 22: 732-738, 1995.
16. Henrich, W. L., J. R. Falck, and W. B. Campbell. Inhibition of renin release by 14,15-epoxyeicosatrienoic acid in renal cortical slices. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E269-E274, 1990.
17. Itnig, J. D., and L. G. Navar. Afferent arteriolar response to arachidonic acid: involvement of metabolic pathways. Am. J. Physiol. 271 (Renal Fluid Electrolyte Physiol. 40): F87-F93, 1996.
18. Imig, J. D., L. G. Navar, R. J. Roman, K. K. Reddy, and J. R. Falck. Actions of epoxygenase metabolites on the preglomerular vasculature. J. Am. Soc. Nephrol. 7: 2364-2370, 1996.
19. Imig, J. D., A. P. Zou, D. E. Stec, D. R. Hàrder, J. R. Falck, and R. J. Roman. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R217-R227, 1996.
20. Isenring, P., M. Lebel, P. Falardeau, and J. H. Grose. Eicosanoid modulation of the norepinephrine effect on blood pressure and renal hemodynamics in humans. Prostaglandins Leukot. Essent. Fatty Acids 54: 59-63, 1996.
21. Jiang, M. J., and K. G. Morgan. Intracellular calcium levels in phorbol ester-induced contractions of vascular smooth muscle. Am. J. Physiol. 253 (Heart Circ. Physiol. 22): H1365-H1371, 1987.
22. Jim, K., A. Hassid, F. Sun, and M. J. Dunn. Lipoxygenase activity in rat kidney glomeruli, glomerular epithelial cells, and cortical tubules. J. Biol. Chem. 257: 10294-10299, 1982.
23. 2, 12-lipoxygenase, and cyclooxygenase inhibitors in the feline pulmonary bed. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L573-L579, 1997.
24. 2. Am. J. Physiol. 266 (Renal Fluid Electrolyte Physiol. 35): F202-F209, 1994.
25. Ma, Y. H., D. Gebremedhin, M. L. Schwartzman, J. R. Falck, J. E. Clark, B. S. S. Masters, D. R. Harder, and R. J. Roman. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ. Res. 72: 126-136, 1993.
26. Ma, Y. H., D. R. Harder, J. E. Clark, and R. J. Roman. Effects of 12-HETE on isolated dog renal arcuate arteries. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H451-H456, 1991.
27. Natarajan, R., N. Gonzales, L. Lanting, and J. Nadler. Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy. Hypertension 23: I-142-I-147, 1994.
28. Navar, L. G., E. W. Inscho, D. S. A. Majid, J. D. Imig, L. M. Harrison-Bernard, and K. D. Mitchell. Paracrine regulation of the renal microcirculation. Physiol. Rev. 76: 425-536, 1996.
29. Nozawa, K., M. L. Tuck, M. Golub, P. Eggena, J. L. Nadler, and N. Stern. Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H1774-H1780, 1990.
30. Omata, K., N. G. Abraham, B. Escalante, and M. L. Schwartzman. Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F8-F16, 1992.
31. 2. Am. J. Physiol. 266 (Renal Fluid Electrolyte Physiol. 35): F850-F857, 1994.
32. 1 receptors in endothelial cells. Br. J. Pharmacol. 118: 79-84, 1996.
33. 2 in vascular smooth-muscle cells. Biochem. J. 299: 197-201, 1994.
34. Scharschmidt, L. A., J. G. Douglas, and M. J. Dunn. Angiotensin II and eicosanoids in the control of glomerular size in the rat and human. Am. J. Physiol. 250 (Renal Fluid Electrolyte Physiol. 19): F348-F356, 1986.
35. Sekiya, K., and H. Okuda. Selective inhibition of platelet lipoxygenases by baicalein. Biochem. Biophys. Res. Commun. 105: 1090-1095, 1982.
36. Stern, N., M. Golub, K. Nozawa, M. Berger, E. Knoll, N. Yanagawa, R. Natarajan, J. L. Nadler, and M. L. Tuck. Selective inhibition of angiotensin II-mediated vasoconstriction by lipoxygenase blockade. Am. J. Physiol. 257 (Heart Circ. Physiol. 26): H434-H443, 1989.
37. 2. Biochemistry 32: 5935-5940, 1993.
38. 2 mediates the antihypertensive effect of a lipoxygenase inhibitor in rats with angiotensin II-induced hypertension (Abstract). Hypertension 26: 544, 1995.
39. Wilcox, C. S., and W. J. Welch. Thromboxane mediation of the pressor response to infused angiotensin II. Am. J. Hypertens. 3: 242-249, 1990.
40. Wolf, G., E. G. Neilson, S. Goldfarb, and F. N. Ziyadeh. The influence of glucose concentration on angiotensin II-induced hypertrophy of proximal tubular cells in culture. Biochem. Biophys. Res. Commun. 176: 902-909, 1991.
41. Wood, J. M., W. Studer, R. Stadler, and K. G. Hofbauer. Effects of endogenous arginine-vasopressin on renal, mesenteric and femoral vascular resistance in the rat. NZ Med. J. 96: 918-920, 1983.
42. 42a. Wu, X. C., N. T. Richards, J. Michael, and E. Johns. Relative roles of nitric oxide and cyclo-oxygenase and lipoxygenase products of arachidonic acid in the contractile responses of rat renal arcuate arteries. Br. J. Pharmacol. 112: 369-376, 1994.
43. Zhang, B. L., and J. Sassard. Eicosanoid-dependence of responses of pre- but not postglomerular vessels to noradrenaline in rat isolated kidneys. Br. J. Pharmacol. 110: 235-238, 1993.
44. Zou, A.-P., J. D. Imig, P. R. Ortiz de Montellano, Z. Sui, and R. J. Roman. Inhibition of renal vascular 20-HETE impairs autoregulation of renal blood flow. Am. J. Physiol. 266 (Renal Fluid Electrolyte Physiol. 35): F275-F282, 1994.